CPG
TEVA icon

Cornerstone Planning Group’s Teva Pharmaceuticals TEVA Stock Holding History

Cornerstone Planning Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9K Hold
893
– – ﹤0.01% 577
2026
Q1 		$32K Buy
893
+755
+547% +$24.3K ﹤0.01% 526
2025
Q4 		$4.58K Sell
138
-83
-38% -$2.04K ﹤0.01% 1011
2025
Q3 		$17.6K Buy
221
+165
+295% +$2.9K ﹤0.01% 624
2025
Q2 		$880 Buy
56
+38
+211% +$613 ﹤0.01% 1141
2025
Q1 		$257 Sell
18
-87
-83% -$1.55K ﹤0.01% 1439
2024
Q4 		$2.29K Buy
105
+86
+453% +$1.56K ﹤0.01% 762
2024
Q3 		$350 Buy
19
+18
+1,800% +$315 ﹤0.01% 1161
2024
Q2 		$17 Hold
1
– – ﹤0.01% 1235
2024
Q1 		$14 Hold
1
– – ﹤0.01% 1082
2023
Q4 		$10 Hold
1
– – ﹤0.01% 949
2023
Q3 		$10 Buy
+1
New +$9 ﹤0.01% 1192

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Cornerstone Planning Group's TEVA Position: Q2 2026 in Review

Cornerstone Planning Group held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 893 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #577.

Cornerstone Planning Group first reported a position in TEVA in Q3 2023 and has held it in 12 quarters since. The position peaked at $32K in Q1 2026. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Cornerstone Planning Group held 893 shares of Teva Pharmaceuticals worth $26.9K as of Q2 2026.
  • Cornerstone Planning Group left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #577 holding.
  • Cornerstone Planning Group first reported a position in Teva Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Cornerstone Planning Group's Teva Pharmaceuticals position peaked at $32K in Q1 2026.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.